TJP adds FX2 Virtual
The acquisition adds a virtual commercial operations capability that bridges access strategy and field execution for pharmaceutical and biotech clients.
Takeaways
- FX2 Virtual is a life sciences commercial operations agency providing virtual sales, reimbursement support, and omnichannel analytics.
- TJP is acquiring FX2 Virtual with backing from Renovus Capital Partners.
- The business serves life sciences.
Renovus Capital Partners-backed TJP has acquired FX2 Virtual, a life sciences commercial operations agency providing virtual sales forces, patient access reimbursement support, and omnichannel data analytics.
Founded by pharmaceutical industry veterans Ed Kessig, Jeff Cino and Sal Paolozza, FX2 Virtual will operate as a standalone brand under TJP.
“We are thrilled to join forces with TJP and Renovus Capital to close the loop between access strategy and field execution,” said Ed Kessig, Founding Partner FX2 Virtual.
The combination pairs TJP’s market access and patient journey design capabilities with FX2’s virtual sales and key account management teams to offer clients a single partner connecting strategy to commercial pull-through.
Fairmount Partners acted as exclusive adviser to FX2 Virtual.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.